EU Pushes For Compulsory Licensing Of Drugs & Vaccines In Health Crises
Activists Welcome 'Surprise' Move But Industry Disappointed
Executive Summary
The EU has published an action plan that is intended to upgrade the bloc’s intellectual property framework while ensuring that goods such as medicines and vaccines are made as widely available as possible. The initiative is part of wide-ranging plans to support member states’ recovery from the pandemic crisis and help ensure the EU’s resilience to future health threats.